Antiplatelet monotherapy after percutaneous coronary intervention
- PMID: 40467074
- DOI: 10.1136/bmj.r1089
Antiplatelet monotherapy after percutaneous coronary intervention
Conflict of interest statement
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare that there are no other relevant conflicts of interest.
Publication types
LinkOut - more resources
Full Text Sources